Biodexa Pharmaceuticals Plc (BDRX) Form 424B3 — Oct 13, 2026
Biodexa Pharmaceuticals filed Prospectus Supplement No. 5 to its resale prospectus covering 29,926,150 ordinary shares (598,523 ADSs), incorporating an October 8, 2026 Form 6-K. The 6-K announces a ratio change of the company's ADSs from one ADS per 50 ordinary shares to one ADS per 400 ordinary shares, effective on or about October 26, 2026. ADS holders must mandatorily exchange eight old ADSs for one new ADS (new CUSIP 59564R864), an effect equivalent to a one-for-eight reverse ADS split; ordinary shares are unaffected.
Key figures
- Offering Price
- 0.3832
- Shares Offered
- 29926150
- Ads covered
- 598523
- New ads ratio
- 1 ADS = 400 ordinary shares
- Old ads ratio
- 1 ADS = 50 ordinary shares
- Effective date
- on or about October 26, 2026
- Reverse split ratio
- 1-for-8 (ADS level)
- Ordinary shares covered
- 29926150
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.